Page results
-
Clinician researchers at UCLH and UCL are leading a major UK clinical trial to test whether proton beam therapy (PBT) can significantly improve survival for patients with mesothelioma, a rare and aggressive cancer of the lining of the lung.
-
Having proton beam therapy: information for teenagers aged 13-17 patient information.
-
Having proton beam therapy: information for children aged 9-12 patient information
-
Having proton beam therapy: information for children aged 5-8 patient information page.
-
University College London Hospitals (UCLH) is now administering new COVID-19 treatments for patients at highest risk in the community.
-
Mixed sex accommodation and privacy information for patients coming into hospital for an inpatient stay
-
UCLH NHS Foundation Trust has once again formed a partnership with the Business Design Centre in Islington to reopen a large-scale COVID-19 vaccination centre on site from Saturday 18 December.
-
This page answers common questions asked by colorectal patients.
-
Information on how we ask for your consent to treatment, and Martha's Rule.
-
UCLH is accelerating clinical trial delivery so that patients gain access to new treatments sooner. The acceleration is happening through close collaboration between research teams and clinical services.
File results
-
FOI/2022/0193 - Drug treatment for breast cancer
-
FOI/2022/0194 - Drug treatment for lung cancer
-
FOI/2022/0199 - Trust postal service and patient communication
-
FOI/2022/0200 - IT budget/ chatbots
-
FOI/2022/0205 - Spending on communication activities
-
FOI/2022/206 - Rates for Bonham Carter House 52-54 Gower Street
-
FOI/2022/0207 - Patient treatment with Nivolumab
-
FOI/2022/0209 - Patient tracking list or waiting lists
-
FOI/2022/0211 - Enteral feeding machine mechanical insufflator
-
FOI/2022/0212 - Clotting disorders medication